Journal of Ophthalmic Inflammation and Infection
Scope & Guideline
Exploring the frontiers of ophthalmic disease management.
Introduction
Aims and Scopes
- Ocular Inflammatory Diseases:
The journal extensively covers various types of ocular inflammatory conditions, including uveitis, scleritis, and keratitis, emphasizing their clinical characteristics, treatment options, and management strategies. - Infectious Ocular Diseases:
Research on infectious diseases affecting the eye such as endophthalmitis, keratitis, and conjunctivitis is a core focus, including investigations into causative pathogens and their susceptibility to treatment. - Innovative Diagnostic Techniques:
The journal promotes the use of advanced diagnostic methods, including imaging technologies like optical coherence tomography and molecular techniques such as PCR, to enhance the accuracy of diagnosis in ophthalmology. - Clinical Case Studies:
The publication features detailed case reports that provide insights into rare and complex ocular conditions, contributing to a better understanding of clinical presentations and treatment outcomes. - Therapeutic Advances:
A significant aim of the journal is to report on new therapeutic approaches, including the use of biologics, corticosteroids, and novel drug delivery systems, aimed at improving patient outcomes in ocular inflammation and infection.
Trending and Emerging
- Impact of COVID-19 on Ocular Health:
There is a growing body of work investigating the ocular manifestations and complications associated with COVID-19, including post-vaccination effects, indicating a heightened awareness and research interest in this area. - Biologics and Novel Therapies:
An increasing number of studies are exploring the use of biologics and new therapeutic agents for managing inflammatory ocular diseases, showcasing the journal's commitment to reporting cutting-edge treatment options. - Microbial Resistance Patterns:
Research focusing on antimicrobial resistance in ocular pathogens is on the rise, reflecting a global concern about treatment efficacy and the need for updated guidelines in managing ocular infections. - Advanced Imaging Techniques:
There is a trend towards more publications utilizing advanced imaging modalities, such as OCT angiography and in vivo confocal microscopy, to enhance diagnostic accuracy and patient management strategies. - Multidisciplinary Approaches in Ocular Disease Management:
The journal is increasingly featuring studies that incorporate a multidisciplinary approach, combining ophthalmology with other medical fields like rheumatology and infectious diseases, to provide holistic patient care.
Declining or Waning
- Traditional Surgical Techniques:
There has been a noticeable decrease in publications focused on conventional surgical methods for treating ocular diseases, possibly due to the rise of less invasive and more effective therapeutic alternatives. - General Microbial Keratitis Studies:
Although still relevant, general studies on microbial keratitis without specific emphasis on emerging pathogens or novel treatment approaches have become less frequent, reflecting a shift towards more targeted investigations. - Non-Infectious Uveitis Studies:
Research specifically dedicated to non-infectious uveitis, particularly studies not involving new treatment protocols or significant case series, appears to be declining in favor of more comprehensive studies involving infectious or complex cases. - Epidemiological Surveys:
The publication of broad epidemiological studies related to ocular infections is decreasing, likely as the focus shifts towards more detailed and actionable clinical research. - Basic Science Research:
There seems to be a reduction in the number of papers focusing on basic science aspects of ocular inflammation and infection, as the journal emphasizes clinical applications and case-oriented research.
Similar Journals
OCULAR IMMUNOLOGY AND INFLAMMATION
Exploring the complexities of immune responses in the eye.Ocular Immunology and Inflammation is a distinguished academic journal dedicated to advancing the field of ocular immunology and ophthalmic inflammation. Published by Taylor & Francis Inc, this journal plays a crucial role in disseminating high-quality research findings, reviews, and clinical studies that address the complexities of immune responses in the eye and their implications in various ocular diseases. With an impressive impact factor and consistently ranking in the Q2 category in both Immunology and Allergy and Ophthalmology, it stands out as a vital resource for researchers, clinicians, and students alike. The journal's broad scope encompasses both experimental and clinical studies, ensuring a comprehensive exploration of the mechanisms and treatments of ocular inflammatory conditions. With its publication history dating from 1993 to 2024, this journal continues to be an essential reference for those seeking cutting-edge research and insights into ocular health. Researchers and professionals are encouraged to engage with the latest articles to inform their practice and advance their knowledge in this critical area of medicine.
MOLECULAR VISION
Unlocking the mysteries of vision, one study at a time.MOLECULAR VISION is a premier open-access journal that has been advancing the field of ophthalmology since its inception in 1995. Published by MOLECULAR VISION, this journal boasts a strong reputation, currently ranking in the second quartile (Q2) of its category, with a Scopus ranking of 35 out of 137, placing it in the 74th percentile among peer publications. Dedicated to disseminating groundbreaking research and innovative findings in the study of vision and ocular health, MOLECULAR VISION serves as a vital resource for researchers, healthcare professionals, and students engaged in this dynamic field. The journal welcomes contributions spanning fundamental and clinical research, offering a platform for crucial knowledge exchange that is essential for advancing ocular health and function. With its commitment to open access, readers around the globe can freely access and build upon the wealth of information disseminated through its pages, ensuring that the latest developments in ophthalmology are available to all.
OPHTHALMIC RESEARCH
Illuminating Insights in Ophthalmology and NeuroscienceOphthalmic Research, with ISSN 0030-3747 and E-ISSN 1423-0259, is a distinguished peer-reviewed journal published by Karger in Switzerland. Established in 1970, this journal serves as a vital resource for exploration and dissemination of knowledge within the fields of Ophthalmology, Cellular and Molecular Neuroscience, and Sensory Systems, maintaining its relevance through its convergence into modern research methodologies leading up to 2024. With impressive rankings in 2023, it holds a Q2 quartile in both Ophthalmology and Medicine (miscellaneous), reflecting its significant contribution to the academic community, alongside Scopus ranks that position it favorably in the competitive landscape of medical and neuroscientific literature. Although not open access, the journal ensures that high-quality research remains accessible to its readership, which includes researchers, professionals, and students eager to stay at the forefront of ophthalmic advancements. By fostering interdisciplinary collaboration and facilitating high-level discourse, Ophthalmic Research is pivotal for those committed to advancing the future of eye care and vision sciences.
JOURNAL FRANCAIS D OPHTALMOLOGIE
Advancing ocular health through innovative research.JOURNAL FRANCAIS D OPHTALMOLOGIE, published by MASSON EDITEUR, is a prominent peer-reviewed journal that serves as a vital resource in the field of ophthalmology. Launched in 1978, this esteemed publication continues to make significant contributions to the advancement of ocular health and vision science, with its scope encompassing clinical practices, innovative research, and the latest technological advancements in ophthalmic care. Based in France, the journal is recognized in the 2023 category quartiles with a Q3 ranking in ophthalmology, reflecting its dedication to quality scholarship within a competitive landscape, as evidenced by its positioning in the 30th percentile of the Scopus rankings. While it operates without Open Access, the journal remains crucial for professionals, researchers, and students alike, providing a platform for sharing knowledge and fostering collaborations in the global ophthalmological community.
Nepalese Journal of Ophthalmology
Empowering Vision Care with Open Access InsightsNepalese Journal of Ophthalmology, established by the NEPAL OPHTHALMIC SOC, is a premier Open Access journal dedicated to advancing the field of ophthalmology. With its ISSN 2072-6805 and E-ISSN 2091-0320, the journal provides an important platform for sharing innovative research and clinical findings in eye health. Since its inception in 2009, the journal has aimed to disseminate high-quality research that addresses contemporary challenges in ophthalmic practices, thus supporting improved patient care and outcomes within Nepal and beyond. The journal has achieved notable recognition, evidenced by its Scopus rank of #267 out of 915 in the field of General Medicine, placing it within the 70th percentile. Researchers, professionals, and students will find valuable information in its comprehensive articles, which cater to a multidisciplinary audience interested in the latest developments in ophthalmology. Emphasizing accessibility, the journal ensures that all published content is freely available, fostering collaboration and knowledge sharing in the global medical community.
Case Reports in Ophthalmological Medicine
Fostering Collaboration for Enhanced Eye CareCase Reports in Ophthalmological Medicine, an esteemed journal published by HINDAWI LTD, is a vital resource for researchers and professionals in the field of ophthalmology. With an emphasis on the dissemination of novel case reports and innovative findings, this open-access journal has been providing accessibility to cutting-edge ophthalmological research since 2011, allowing for a broader exchange of knowledge among clinicians and academics. Although specific impact factor and h-index data are not detailed, the journal is committed to fostering a collaborative environment for the global ophthalmology community, promoting evidence-based practices through rigorously peer-reviewed articles. The journal's dedication to open access ensures that valuable insights reach a wider audience, facilitating advancements in patient care and surgical techniques. Case Reports in Ophthalmological Medicine stands as a pivotal platform for sharing diverse clinical experiences, contributing significantly to the enhancement of ophthalmology as a specialty.
INTERNATIONAL OPHTHALMOLOGY
Advancing Vision Science, One Study at a Time.International Ophthalmology is a prestigious journal published by Springer, dedicated to advancing the field of ophthalmology through the dissemination of high-quality research and clinical studies. With an ISSN of 0165-5701 and an E-ISSN of 1573-2630, this journal has been a vital resource since its inception in 1978, serving the global community of ophthalmologists, researchers, and healthcare professionals. The journal holds a significant Q2 ranking in the category of ophthalmology and has achieved a commendable position as #56 in Scopus's rankings, placing it within the top tier of its field. Although it does not offer open-access options, articles published in International Ophthalmology are widely cited and respected, playing a crucial role in the ongoing dialogue regarding contemporary ophthalmic practices and innovations. With a broad scope covering all aspects of eye care, this journal is essential for those aiming to keep abreast of the latest developments and research findings that shape the future of vision science and clinical practice.
Journal of Current Ophthalmology
Bridging Research and Practice: Enhancing Eye Health TogetherJournal of Current Ophthalmology is a premier scholarly platform dedicated to advancing the field of ophthalmology, published by Wolters Kluwer Medknow Publications. Established as an Open Access journal since 2015, it aims to provide unrestricted access to high-quality research that fosters knowledge sharing and collaboration among researchers, practitioners, and students in the field. The journal covers a broad spectrum of topics within ophthalmology, from clinical practices to groundbreaking research, contributing significantly to the medical community's understanding of eye health and diseases. With an impact factor reflecting its significance, it ranks in the Q2 category of ophthalmology and stands at #66 out of 137 in Scopus rankings, placing it in the 52nd percentile of its field as of 2023. The Journal of Current Ophthalmology is committed to publishing cutting-edge findings and innovative solutions, establishing itself as an essential resource for all professionals engaged in ocular research and care.
Ocular Surface
Illuminating Insights in OphthalmologyOcular Surface, published by Elsevier, stands at the forefront of ophthalmology research, with a notable Impact Factor reflecting its significant contribution to the field. As a vibrant platform for disseminating cutting-edge findings, this journal has achieved Q1 ranking in the Ophthalmology category as of 2023, placing it amongst the top-tier journals globally, specifically ranking 4th out of 137 in Scopus with an impressive 97th percentile. Spanning across the years from 2003 to 2024, Ocular Surface focuses on advancing knowledge in areas such as ocular pathology, therapy, and surgical interventions. While the journal is not open access, it provides invaluable insights and empirical data essential for researchers, professionals, and students dedicated to improving ocular health. With an address rooted in Amsterdam, Netherlands, this esteemed journal continues to enrich the global conversation in ophthalmology.
CORNEA
Advancing ocular health through cutting-edge research.CORNEA is a prestigious peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the rapidly advancing field of ophthalmology with a particular emphasis on corneal research and diseases. With an impact factor categorized in the prestigious Q1 quartile for its discipline, CORNEA has established itself as a leading platform for the dissemination of both fundamental and clinical studies since its inception in 1982. The journal is ranked 25th out of 137 in the Scopus Medicine-Ophthalmology category, placing it in the 82nd percentile among its peers, which underscores its vital role in influencing ocular research and clinical practices. While the journal is not currently open access, it provides valuable insights and updates for professionals, researchers, and students working to advance knowledge in corneal health, contributing significantly to the ongoing dialogue in the ophthalmological community. With a commitment to excellence, CORNEA continues to publish high-quality research and reviews in its pursuit to improve ocular outcomes and patient care.